Intraductal carcinoma of the breast: follow-up after biopsy only.
about
Increased copy number at 3p14 in breast cancerDiscrepancies in the diagnosis of intraductal proliferative lesions of the breast and its management implications: results of a multinational surveyThe diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classificationDuctal carcinoma in situ: terminology, classification, and natural historyTumour markers in breast carcinoma correlate with grade rather than with invasivenessEpidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-upThe utility of linked cancer registry and health administration data for describing system-wide outcomes and research: a BreastScreen example.Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.Differential expression of follistatin and FLRG in human breast proliferative disordersAtypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology.DCIS grading schemes and clinical implications.Loss of heterozygosity in lobular carcinoma in situ of the breast.Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ?Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?New relationships between breast microcalcifications and cancer.Status of Intraductal Therapy for Ductal Carcinoma in Situ.Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.Radiotherapy for ductal carcinoma in situ detected by screening.Screening women at increased risk with MRIDuctal carcinoma in situ: a brief review of treatment variation and impacts on patients and society.Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer.Intraductal therapy of ductal carcinoma in situ: a presurgery study.Intraoperative radiotherapy in the treatment of breast cancer: a review of the evidenceAmplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.Validation: the new challenge for pathology.Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsiesEvidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breastMutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.The biology of incipient, pre-invasive or intraepithelial neoplasia.Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey.Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.
P2860
Q24530212-694BADBB-9A34-4C12-9CE2-44C8824066FDQ24675897-8E2D6D63-16A6-4013-A6BA-3F2BF61E41F8Q24803360-4D03EAE4-2E10-4DA1-96C1-5DF615C84649Q28296046-0D96F23A-12EB-47A3-AB03-B71C1C938144Q28352534-39CA8AE2-7E12-4886-9139-097A85EA159BQ30251732-FEF2629E-3C79-448D-AAB7-C9A5F92BFE94Q30512858-51FDAD33-6212-4608-B23F-56A335A85B2CQ30646728-AF0311ED-3351-4983-938C-A43C6630E417Q31061505-81893660-75CE-4FCD-9919-270DCFE642F8Q33374153-4D5F4D7B-E9FC-4558-93F9-B471B97CB17CQ33501385-16C9DF0C-1E0C-4D8C-BB6F-0FAD53F34C23Q33723770-0350492C-6425-43ED-91FA-4EA5E9AFEFF9Q33785753-E0C1D132-0E81-479F-8FBD-92DE808FC121Q33836982-99DCDE89-0B18-4F7E-8A53-102F4A445661Q34077045-DB40CD15-1F82-4621-B6C5-01ADA3B22EBFQ34097211-D7DF41F0-60F4-4BCB-AA1F-27159DA8ED88Q34250206-E5912539-8CD9-4B01-A7C8-1890F683F866Q34330061-266E6CF4-6FC7-4B41-9B0F-350FF886285BQ35023352-CC05C4BC-6DFC-45B4-AB5F-4D8E36B72E88Q35069457-A6143C45-3618-4409-8E5C-2C66D0CB5427Q35170151-BED35DC1-0047-4DEB-BC68-6EBEC4EC859BQ35173107-E314099D-C11C-4A88-AFA7-C4668AF09A46Q35213089-94F60714-0F45-4A37-A5DA-C14665FF6F6BQ35586399-A26AF696-0327-4A33-A8AE-E227C060A25BQ35637342-AD30A8FC-F650-40F6-9E4B-2173D4F9AB28Q35684430-13CBF349-E57F-4F3C-B91A-76E815B8B4FFQ35763656-D18E7D3C-432C-4ECD-87CE-8846F52B5097Q35764821-0A2434C7-CE47-4BFF-891C-2B6149CE197AQ35775640-604CAB4B-F59D-4F21-AA0C-D3115FECB3E9Q35794436-AE4A8E23-8213-405F-89D2-4AEE7D75B0FDQ35812494-891FB219-B71A-46C1-AEA8-0289F20542B8Q35846896-4088DABA-22C0-4761-8741-3A866CB1E1AEQ36029584-B64B7A75-89AC-4E07-B5AA-163F51CE1B86Q36114994-9EEFA206-D3F8-4EF6-9DEA-CC2A514D336CQ36134576-0CBFE66C-9B4D-468B-891E-A83503DC2E1CQ36136580-8302987D-A93A-4C4C-9FA2-453DEB1DB0B8Q36198186-D41C0B8D-3EF6-461A-A340-099A839D515FQ36539575-9E38EF14-95B3-447E-B6A1-CA24E05C95A7Q36587186-A86885C2-E10F-46FD-AF86-3D8643C1ECC4Q36624054-DEE79842-1571-44A8-B9F7-6D7B9EFB376B
P2860
Intraductal carcinoma of the breast: follow-up after biopsy only.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Intraductal carcinoma of the breast: follow-up after biopsy only.
@en
type
label
Intraductal carcinoma of the breast: follow-up after biopsy only.
@en
prefLabel
Intraductal carcinoma of the breast: follow-up after biopsy only.
@en
P2093
P1433
P1476
Intraductal carcinoma of the breast: follow-up after biopsy only.
@en
P2093
Landenberger M
P304
P356
10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y
P407
P577
1982-02-01T00:00:00Z